Safety and Tolerability of the BNT162b2 mRNA COVID-19 Vaccine in Dialyzed Patients. COViNEPH Project

Background and Objectives: The Pfizer-BioNTech (BNT162b2) COVID-19 mRNA vaccine has demonstrated excellent efficacy and safety in phase 3 trials. However, no dialyzed patients were included, and therefore safety data for this patient group is lacking. The aim of the study was to assess the safety an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicina (Kaunas)
Hlavní autoři: Polewska, Karolina, Tylicki, Piotr, Biedunkiewicz, Bogdan, Rucińska, Angelika, Szydłowska, Aleksandra, Kubanek, Alicja, Rosenberg, Iwona, Rodak, Sylwia, Ślizień, Waldemar, Renke, Marcin, Dębska-Ślizień, Alicja, Tylicki, Leszek
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8307559/
https://ncbi.nlm.nih.gov/pubmed/34357013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57070732
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky